Prabhjot Kaur
Pharmacokinetic Scientist at Altasciences- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Fundamentals of Pharmacokinetics
CertaraJan, 2022- Nov, 2024 -
Introduction to Pheonix WNL
CertaraDec, 2021- Nov, 2024 -
Non Compartmental Data Analysis
CertaraDec, 2021- Nov, 2024
Experience
-
Altasciences
-
Canada
-
Research Services
-
700 & Above Employee
-
Pharmacokinetic Scientist
-
Sep 2021 - Present
PK/PD lead in Clinical Phase 1 to Phase 3 studies, involved at various stages like protocol development, SAP, SAP shells, PK population, WNL Analysis, TFLs generation and PK sections of CSR. TKPI in complex TK studies involving ADA analysis, establishing dose relationship, gender effect and tissue analysis.SME for WNL NCA analysis providing Scientific advice to the team.Training of new hires. PK/PD lead in Clinical Phase 1 to Phase 3 studies, involved at various stages like protocol development, SAP, SAP shells, PK population, WNL Analysis, TFLs generation and PK sections of CSR. TKPI in complex TK studies involving ADA analysis, establishing dose relationship, gender effect and tissue analysis.SME for WNL NCA analysis providing Scientific advice to the team.Training of new hires.
-
-
-
Pharmaron US Lab Services
-
United States
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Associate Scientific Operations Manager
-
Jul 2021 - Sep 2021
Managing smooth functioning of BA studies Preclinical PK WNL analysis and Reporting
-
-
Research Scientist
-
Feb 2020 - Jun 2021
QC review of ADME reports, BA data, PK reports, PK data, MetID reports and data.PK scientist for precinical WNL PK Analysis, Drafting preclinical PK reports.
-
-
-
Syngene International Limited
-
India
-
Research Services
-
700 & Above Employee
-
Deputy Manager
-
Oct 2006 - Feb 2011
• Analytical Project Lead for GMP pharmaceutical projects from US and Europe Sponsors• Responsible for method development using HPLC, GC, LC-MS, and GC-MS for reaction monitoring involving intermediate steps and for finished drug products • Validating the developed methods, carrying out release testing for shipments along with the compilation of the technical package • Contributed to the analytical part for DMF regulatory submissions• Worked as a test item controller and study director for GLP studies
-
-
-
SUN PHARMA
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Research Scientist
-
Oct 2003 - May 2006
• Analytical method development for related substances and impurities, establishing chiral purity, Assay, reaction monitoring on HPLC and occasionally on GC for new DMF API projects• Performing stability testing of API drugs• Validation of the developed methods on HPLC and GLC• Compiling development reports, method transfers, specifications and standard testing procedure (STPs) • Analytical method development for related substances and impurities, establishing chiral purity, Assay, reaction monitoring on HPLC and occasionally on GC for new DMF API projects• Performing stability testing of API drugs• Validation of the developed methods on HPLC and GLC• Compiling development reports, method transfers, specifications and standard testing procedure (STPs)
-
-
-
Morepen Laboratories Limited India
-
India
-
Pharmaceutical Manufacturing
-
500 - 600 Employee
-
Executive
-
Jan 2002 - Oct 2003
• Analysis of impurities and reaction monitoring on HPLC• Analysis of residual solvents of API drug on HS-GC• Worked in QC in GMP USFDA approved generics plant • Analysis of impurities and reaction monitoring on HPLC• Analysis of residual solvents of API drug on HS-GC• Worked in QC in GMP USFDA approved generics plant
-
-
Education
-
-
Indian Institute of Technology, Delhi
Master of Technology, Analytical Chemistry -
-
Panjab University
Master of Science, Organic Chemistry -
-
Panjab University
Bachelor of Science, Chemistry
Community
